Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Cancer Cell. 2022 May 9;40(5):509-523.e6. doi: 10.1016/j.ccell.2022.04.004. Epub 2022 May 9.
Cancer Cell. 2022.
PMID: 35537412